Heart-Sparing proton therapy tested in advanced breast cancer

NCT ID NCT01758445

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 32 times

Summary

This study tests a precise type of radiation called proton therapy given after surgery for stage II/III breast cancer. The goal is to see if it can effectively treat cancer while reducing damage to the heart and other organs. About 220 women will receive this treatment and be followed for up to 15 years to check for side effects and long-term outcomes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Hampton University Proton Therapy Institute

    Hampton, Virginia, 23666, United States

  • Maryland Proton Treatment Center

    Baltimore, Maryland, 21201, United States

  • Northwestern Medicine Chicago Proton Center

    Warrenville, Illinois, 60555, United States

  • Oklahoma Proton Center

    Oklahoma City, Oklahoma, 73142, United States

  • Princeton ProCure Managment LLC

    Somerset, New Jersey, 08873, United States

Conditions

Explore the condition pages connected to this study.